Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Comparative study of nanoparticle-mediated transfection in different GI epithelium co-culture models.

Loo Y, Grigsby CL, Yamanaka YJ, Chellappan MK, Jiang X, Mao HQ, Leong KW.

J Control Release. 2012 May 30;160(1):48-56. doi: 10.1016/j.jconrel.2012.01.041. Epub 2012 Feb 3.

2.

Facilitated nanoscale delivery of insulin across intestinal membrane models.

Woitiski CB, Sarmento B, Carvalho RA, Neufeld RJ, Veiga F.

Int J Pharm. 2011 Jun 30;412(1-2):123-31. doi: 10.1016/j.ijpharm.2011.04.003. Epub 2011 Apr 8.

PMID:
21501675
3.

Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles.

Schimpel C, Teubl B, Absenger M, Meindl C, Fröhlich E, Leitinger G, Zimmer A, Roblegg E.

Mol Pharm. 2014 Mar 3;11(3):808-18. doi: 10.1021/mp400507g. Epub 2014 Feb 6.

PMID:
24502507
4.

Models and methods to evaluate transport of drug delivery systems across cellular barriers.

Ghaffarian R, Muro S.

J Vis Exp. 2013 Oct 17;(80):e50638. doi: 10.3791/50638.

5.

Vitamin B12 functionalized layer by layer calcium phosphate nanoparticles: A mucoadhesive and pH responsive carrier for improved oral delivery of insulin.

Verma A, Sharma S, Gupta PK, Singh A, Teja BV, Dwivedi P, Gupta GK, Trivedi R, Mishra PR.

Acta Biomater. 2016 Feb;31:288-300. doi: 10.1016/j.actbio.2015.12.017. Epub 2015 Dec 11.

PMID:
26685755
6.

Transport of chitosan-DNA nanoparticles in human intestinal M-cell model versus normal intestinal enterocytes.

Kadiyala I, Loo Y, Roy K, Rice J, Leong KW.

Eur J Pharm Sci. 2010 Jan 31;39(1-3):103-9. doi: 10.1016/j.ejps.2009.11.002. Epub 2009 Nov 12.

7.

Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.

Sadeghi AM, Dorkoosh FA, Avadi MR, Weinhold M, Bayat A, Delie F, Gurny R, Larijani B, Rafiee-Tehrani M, Junginger HE.

Eur J Pharm Biopharm. 2008 Sep;70(1):270-8. doi: 10.1016/j.ejpb.2008.03.004. Epub 2008 Mar 12.

PMID:
18492606
8.

Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.

Yuan H, Chen CY, Chai GH, Du YZ, Hu FQ.

Mol Pharm. 2013 May 6;10(5):1865-73. doi: 10.1021/mp300649z. Epub 2013 Apr 5.

PMID:
23495754
9.

Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.

Hilgendorf C, Spahn-Langguth H, Regårdh CG, Lipka E, Amidon GL, Langguth P.

J Pharm Sci. 2000 Jan;89(1):63-75.

PMID:
10664539
10.

Prolonging the expression duration of ultrasound-mediated gene transfection using PEI nanoparticles.

Lee JL, Lo CW, Ka SM, Chen A, Chen WS.

J Control Release. 2012 May 30;160(1):64-71. doi: 10.1016/j.jconrel.2012.03.007. Epub 2012 Mar 15.

PMID:
22465392
11.

Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs.

Antunes F, Andrade F, Araújo F, Ferreira D, Sarmento B.

Eur J Pharm Biopharm. 2013 Apr;83(3):427-35. doi: 10.1016/j.ejpb.2012.10.003. Epub 2012 Nov 16.

PMID:
23159710
12.

Yersinia pseudotuberculosis induces transcytosis of nanoparticles across human intestinal villus epithelium via invasin-dependent macropinocytosis.

Ragnarsson EG, Schoultz I, Gullberg E, Carlsson AH, Tafazoli F, Lerm M, Magnusson KE, Söderholm JD, Artursson P.

Lab Invest. 2008 Nov;88(11):1215-26. doi: 10.1038/labinvest.2008.86.

13.

Surface modified poly(β amino ester)-containing nanoparticles for plasmid DNA delivery.

Fields RJ, Cheng CJ, Quijano E, Weller C, Kristofik N, Duong N, Hoimes C, Egan ME, Saltzman WM.

J Control Release. 2012 Nov 28;164(1):41-8. doi: 10.1016/j.jconrel.2012.09.020. Epub 2012 Oct 5.

14.
15.

A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.

Makhlof A, Werle M, Tozuka Y, Takeuchi H.

J Control Release. 2011 Jan 5;149(1):81-8. doi: 10.1016/j.jconrel.2010.02.001. Epub 2010 Feb 6.

PMID:
20138935
16.

Development of a reduction-sensitive diselenide-conjugated oligoethylenimine nanoparticulate system as a gene carrier.

Cheng G, He Y, Xie L, Nie Y, He B, Zhang Z, Gu Z.

Int J Nanomedicine. 2012;7:3991-4006. doi: 10.2147/IJN.S32961. Epub 2012 Jul 31.

17.

The transport mechanisms of polymer nanoparticles in Caco-2 epithelial cells.

He B, Lin P, Jia Z, Du W, Qu W, Yuan L, Dai W, Zhang H, Wang X, Wang J, Zhang X, Zhang Q.

Biomaterials. 2013 Aug;34(25):6082-98. doi: 10.1016/j.biomaterials.2013.04.053. Epub 2013 May 18.

PMID:
23694903
18.

[Transport of PLGA nanoparticles across Caco-2/HT29-MTX co-cultured cells].

Wen Z, Li G, Lin DH, Wang JT, Qin LF, Guo GP.

Yao Xue Xue Bao. 2013 Dec;48(12):1829-35. Chinese.

PMID:
24689242
19.

Cellular evaluation of insulin transmucosal delivery.

López JE, Peppas NA.

J Biomater Sci Polym Ed. 2004;15(4):385-96.

PMID:
15212324
20.

Supplemental Content

Support Center